Page last updated: 2024-12-10

preussin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

preussin: from Aspergillus ochraceus [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3081195
SCHEMBL ID852408
MeSH IDM0162592

Synonyms (12)

Synonym
l-657,398
3-pyrrolidinol, 1-methyl-5-nonyl-2-(phenylmethyl)-
preussin, (+)-isomer
119463-16-0
l 657398
3-pyrrolidinol, 1-methyl-5-nonyl-2-(phenylemthyl)-
preussin
2-benzyl-1-methyl-5-nonylpyrrolidin-3-ol
SCHEMBL852408
ncgc00385689-01!2-benzyl-1-methyl-5-nonylpyrrolidin-3-ol
DTXSID00922975
AKOS040753610

Research Excerpts

Overview

Preussin was found to be a potent inhibitor of cyclin E kinase (CDK2-cyclin E) in vitro (50% inhibitory concentration; approximately 500 nM) and to inhibit cell cycle progression into S phase.

ExcerptReferenceRelevance
"Preussin was found to be a potent inhibitor of cyclin E kinase (CDK2-cyclin E) in vitro (50% inhibitory concentration; approximately 500 nM) and to inhibit cell cycle progression into S phase."( Inhibition of cyclin-dependent kinase activity and induction of apoptosis by preussin in human tumor cells.
Achenbach, TV; Bach, T; Brummerhop, H; Müller, R; Slater, EP, 2000
)
1.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (10.00)18.7374
1990's1 (5.00)18.2507
2000's8 (40.00)29.6817
2010's8 (40.00)24.3611
2020's1 (5.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.38 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]